{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:56Z","timestamp":1790692076193,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.transci.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T02:00:20Z","timestamp":1462154420000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Defining the genetics of thrombotic microangiopathies"],"prefix":"10.1016","volume":"54","author":[{"given":"Paula","family":"Vieira-Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"El Sissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Bordereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Rosain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2016.04.011_bib0010","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.04.011_bib0015","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MOP.0b013e32835d7f2c","article-title":"Update on Streptococcus pneumoniae associated hemolytic uremic syndrome","volume":"25","author":"Spinale","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.transci.2016.04.011_bib0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/INF.0b013e31829ee872","article-title":"Diagnosis of Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"32","author":"Loupiac","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.transci.2016.04.011_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0035","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.04.011_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.transci.2016.04.011_bib0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0050","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.thromres.2014.09.004","article-title":"Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): a short review","volume":"134","author":"Perez-Rodriguez","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2016.04.011_bib0055","doi-asserted-by":"crossref","first-page":"29167","DOI":"10.1074\/jbc.M115.683268","article-title":"Structural Insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking","volume":"290","author":"Froese","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transci.2016.04.011_bib0060","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/humu.21107","article-title":"Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC)","volume":"30","author":"Richard","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.transci.2016.04.011_bib0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-014-9687-6","article-title":"Clinical presentation and outcome in a series of 88 patients with the cblC defect","volume":"37","author":"Fischer","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.transci.2016.04.011_bib0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jhg.2010.81","article-title":"Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria","volume":"55","author":"Liu","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0075","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(15)00076-8","article-title":"Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency","volume":"386","author":"Grange","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2016.04.011_bib0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2013.08.031","article-title":"Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency","volume":"63","author":"Cornec-Le Gall","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2016.04.011_bib0085","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-2581","article-title":"Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency","volume":"132","author":"Komhoff","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2016.04.011_bib0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/humu.21001","article-title":"Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations","volume":"30","author":"Lerner-Ellis","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.transci.2016.04.011_bib0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0100","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2014-06-579953","article-title":"Loss of DGKepsilon induces endothelial cell activation and death independently of complement activation","volume":"125","author":"Bruneau","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2016.04.011_bib0105","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1681\/ASN.2013080886","article-title":"Phenotypic expansion of DGKE-associated diseases","volume":"25","author":"Westland","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0110","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.08520814","article-title":"Characterization of a new DGKE intronic mutation in genetically unsolved cases of familial atypical hemolytic uremic syndrome","volume":"10","author":"Mele","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2016.04.011_bib0120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(73)92645-7","article-title":"Letter: plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura","volume":"2","author":"Cameron","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2016.04.011_bib0125","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00467-014-2933-1","article-title":"Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency","volume":"29","author":"Michaux","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0130","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00467-007-0438-x","article-title":"Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate","volume":"22","author":"Cho","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0135","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.ajkd.2013.05.020","article-title":"Genotype\/phenotype correlations in complement factor H deficiency arising from uniparental isodisomy","volume":"62","author":"Wilson","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2016.04.011_bib0140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.humpath.2010.11.023","article-title":"Heterogeneous pattern of renal disease associated with homozygous factor H deficiency","volume":"42","author":"Servais","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.transci.2016.04.011_bib0145","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.ajkd.2008.02.359","article-title":"Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair","volume":"52","author":"Couzi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2016.04.011_bib0150","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00467-015-3189-0","article-title":"Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome","volume":"30","author":"Bhatia","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0155","doi-asserted-by":"crossref","first-page":"370426","DOI":"10.1155\/2012\/370426","article-title":"Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects","volume":"2012","author":"Bu","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.transci.2016.04.011_bib0160","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140117","article-title":"New functional and structural insights from updated mutational databases for complement factor H, factor I, membrane cofactor protein and C3","volume":"34","author":"Rodriguez","year":"2014","journal-title":"Biosci Rep"},{"key":"10.1016\/j.transci.2016.04.011_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.transci.2016.04.011_bib0170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0175","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.transci.2016.04.011_bib0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0190","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jmedgenet-2014-102498","article-title":"Factors determining penetrance in familial atypical haemolytic uraemic syndrome","volume":"51","author":"Sansbury","year":"2014","journal-title":"J Med Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.transci.2016.04.011_bib0200","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2016.04.011_bib0205","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.transci.2016.04.011_bib0210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2016.04.011_bib0215","first-page":"3861","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0220","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ng.2640","article-title":"A functional variant in the CFI gene confers a high risk of age-related macular degeneration","volume":"45","author":"van de Ven","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski","year":"2015","journal-title":"Hum Genomics"},{"key":"10.1016\/j.transci.2016.04.011_bib0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2016.04.011_bib0235","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2013070796","article-title":"Complement factor B mutations in atypical hemolytic uremic syndrome \u2013 disease-relevant or benign?","volume":"25","author":"Marinozzi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0240","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-10-609073","article-title":"Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations","volume":"125","author":"Schramm","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2016.04.011_bib0245","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ng.2741","article-title":"Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration","volume":"45","author":"Seddon","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1681\/ASN.2013121339","article-title":"A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation","volume":"26","author":"Valoti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0255","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1469-1809.2011.00671.x","article-title":"Age-related penetrance of hereditary atypical hemolytic uremic syndrome","volume":"75","author":"Sullivan","year":"2011","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0260","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0265","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.04.011_bib0270","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1681\/ASN.2015040385","article-title":"High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies","volume":"27","author":"Bu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2016.04.011_bib0275","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","article-title":"Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome","volume":"189","author":"Blanc","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.transci.2016.04.011_bib0280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H-related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.transci.2016.04.011_bib0285","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2016.04.011_bib0290","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1074\/jbc.M114.630871","article-title":"The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease","volume":"290","author":"Bhattacharjee","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transci.2016.04.011_bib0295","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/blood-2012-09-456780","article-title":"Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells","volume":"121","author":"Sorvillo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.transci.2016.04.011_bib0300","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.molimm.2007.01.036","article-title":"The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation","volume":"44","author":"Kavanagh","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.transci.2016.04.011_bib0305","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","article-title":"A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation","volume":"44","author":"Nilsson","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.transci.2016.04.011_bib0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ki.2011.291","article-title":"Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance","volume":"81","author":"Tortajada","year":"2012","journal-title":"Kidney Int"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216300131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216300131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T10:54:39Z","timestamp":1536749679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050216300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1473050216300131"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2016.04.011","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the genetics of thrombotic microangiopathies","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}